has molecular reaction has result has context has agent tamoxifen phospholipase inhibitor[Phospholipidosis] negative regulation of phospholipase-mediated phospholipid degradation by CAD [Phospholipidosis (latent)] Negative regulation of phospholipase-mediated phospholipid degradation by CAD is a subtype of negative regulation of phospholipid degradation: A process that stops, prevents, or reduces the frequency, rate or extent of phospholipase-mediated phospholipid deradation regulated by CAD. This entity is a specific course-dependent process. This process can constitute the course of Phospholipidosis (latent). phospholipidosis (latent) CAD insertion into phospholipase binding site to lysosomal inner membrane [Phospholipidosis (latent)] amiodarone - phospholipase competition inhibitor [Phospholipidosis] imipramine - phospholipase competition inhibitor [Phospholipidosis] negative regulation of phospholipase-mediated phospholipid degradation by CAD [Phospholipidosis] negative regulation of phospholipid hydrolysis [Phospholipidosis (latent)] negative regulation of phospholipid degradation [Phospholipidosis (latent)]